The pharmacodynamics of cisatracurium in healthy adults

Current Opinion in Anaesthesiology

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Savarese, John J ^a   Deriaz, Hugh ^b   Mellinghoff, Hermann ^c   Pavlin, Edward G ^d   Sokoll, Martin D ^e  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b HÔPITAL SAINT ANTOINE   (France)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CHOLINESTERASE INHIBITOR; HISTAMINE; NEUROMUSCULAR BLOCKING AGENT;

BOLUS INJECTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS INFUSION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; HISTAMINE RELEASE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; MUSCLE TWITCH; NEUROMUSCULAR BLOCKING; NORMAL HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; STEREOISOMERISM;

EID: 0029993911     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-199604001-00004     Document Type: Conference Paper

References (28)

1. Stenlake JB: Biodegradable neuromuscular blocking agents. In Advances in Pharmacology and Therapeutics. Edited by Stocklet JC. New York: Pergammon Press; 1978:303-312.
2. Hughes R, Chapple DJ: The pharmacology of atracurium: a new competitive neuromuscular blocking agent Br J Anaesth 1981, 53:31-44.
3. Chapple DJ, Clark JS: Pharmacological action of breakdown of atracurium and related substances. Br J Anaesth 1983, 55 (suppl 1):11S-15S.
4. Ward S, Neil EAM: Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure). Br J Anaesth 1983, 55:1169-1172.
5. Fahey MR, Rupp SM, Fisher DM, Miller RD, Sharma M, Canfell C, Castagnoli K, Hennis PJ: The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology 1984, 61:699-702.
6. Agoston S, Vandenbrom RHG, Wierda JMKH: Clinical pharmacokinetics of neuromuscular blocking drugs. Clin Pharmacokinet 1992, 22:94-115.
7. Marshall IG, Gibb AJ, Durant NN: Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat. Br J Anaesth 1983, 55:703-714.
8. Wastilla WB, Maehr RB: The pharmacological profile of 51W89, the R-cis,R′-cis Isomer of atracurium in cats [abstract]. Anesthesiology 1993, 79:A946.
9. Maehr RB, Wastilla WB: Comparative pharmacology of atracurium and six isomers in cats [abstract]. Anesthesiology 1993, 79:A950.
10. Belmont M, Beemer G, Bownes P, Wastilla W, Savarese J: Comparative pharmacology of atracurium and one of its isomers, 51W89, in rhesus monkeys [abstract]. Anesthesiology 1993, 79:A947.
11. Welsh RM, Brown A, Dahl R: Degradation and metabolism of 51W89, the R-cis,R′-cis isomer of atracurium in human and rat plasma [abstract]. Anesthesiology 1994, 81 (suppl 3A):A1091.
12. Lien CA, Belmont MR, Abalos A, Abou-Donia M, Savarese JJ: Dose response relationships of 51W89 with nitrous oxide/opioid/barbiturate anesthesia [abstract]. Anesthesiology 1993, 79:A948.
13. Lepage JY, Malinovsky JM, Malinge M, Cozian A, Pinaud M: 51W89: Dose response, neuromuscular blocking profile, and cardiovascular effects [abstract]. Anesthesiology 1993, 79:A945.
14. Belmont MR, Lien CA, Quesssy S, Abou-Donia MM, Abalos A, Eppich L, Savarese JJ: The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/oploid/barbiturate anesthesia. Anesthesiology 1995, 82:1139-1145.
15. Lepage JY, Malinovsky JM, Malinge M, Cozian A, Pinaud M: Comparison of equipotent doses of 51W89 and atracurium [abstract]. Anesthesiology 1994, 81 (suppl 3A):A1090.
16. Fisher DM, Rosen JI: A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of non-depolarizing muscle relaxants. Anesthesiology 1986, 65:286-291.
17. Bowman WC, Rodger IW, Houston J, Marshall RJ, McIndewar I: Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 1988, 69:57-62.
18. Kopman A: Pancuronium, gallamine and d-tubocurarine compared: is speed of onset Inversely related to drug potency? Anesthesiology 1989, 70:915-920.
19. Feldman SA: Vecuronium: a variable dose technique. Anaesthesia 1987, 42:199-201.
20. Deriaz H, Schmautz E, Vrillon M, Lienhart A: Pharmacodynamics of repeated doses of 51W89 during surgery [abstract]. Anesthesiology 1994, 81: A1092.
21. Mellinghoff H, Pirpiri P, Buzello W: Comparison of 51W89 and atracurium administered by continuous infusion [abstract]. Anesth Analg 1994, 78 (suppl):S283.
22. Miller RD, Rupp SM, Fisher DM, et al.: Clinical pharmacology of vecuronium and atracurium. Anesthesiology 1984, 61:444-453.
23. 2/propofol anesthesia [abstract]. Anesthesiology 1994, 81:A1117.
24. Gergis SD, Sokoll MD, Mehta M, et al.: Intubation conditions after atracurium and suxamethonium. Br J Anaesth 1983, 55 (suppl):83S-86S.
25. Donati F, Gill SS, Bevan DR, Ducharme J, Theoret Y, Varin F: Pharmacokinetics and pharmacodynamics of atracurium with and without previous suxamethonium administration. Br J Anaesth 1991, 66:557-561.
26. Ono K, Manabe N, Ohta Y, Monta K, Kosaka F: Influence of suxamethonium on the action of subsequently administered vecuronium or pancuronium. Br J Anaeth 1989, 62:324-326.
27. Pavlin EG, Forrest AP, Howard M, Quessy S, McClung C: Prior administration of succinylcholine (SCh) does not affect the duration of Nimbex (51W89) neuromuscular block [abstract]. Anesth Analg 1995, 80 (suppl):S374.
28. Savarese JJ, Viby-Mögensen J, Reich D, van Aken H: The haemodynamic profile of cisatracurium. Curr Opin Anaesthesiol 1996, 9 (suppl 1):S36-S41.